ARHGEF39 promoted non-small cell lung cancer proliferation by stimulating the Rac1-P38-ATF2 signaling pathway and increasing the expression of Cyclin A2, Cyclin D1, and MMP2 (Zhou et al., 2018). This evidence concerns the gene ARHGEF39 and non-small cell lung carcinoma.